Interview with Jamshid Maddahi, MD, on the impact of F-18 flurpiridaz

Jamshid Maddahi, MD, of the University of California, Los Angeles, who led clinical trials for F-18 flurpiridaz, discusses the impact the PET imaging agent may have on heart care following its recent approval.